Magnetic nanocomposites based on hydroxyapatite were prepared by a one-step process using the hydrothermal coprecipitation method to sinter iron oxides (Fe3O4 and γ-Fe2O3). The possibility of expanding the proposed technique for the synthesis of magnetic composite with embedded biologically active substance (BAS) of the 2-arylaminopyrimidine group was shown. The composition, morphology, structural features, and magnetic characteristics of the nanocomposites synthesized with and without BAS were studied. The introduction of BAS into the composite synthesis resulted in minor changes in the structural and physical properties. The specificity of the chemical bonds between BAS and the hydroxyapatite-magnetite core was revealed. The kinetics of the BAS release in a solution simulating the stomach environment was studied. The cytotoxicity of (HAP)FexOy and (HAP)FexOy + BAS composites was studied in vitro using the primary culture of human liver carcinoma cells HepG2. The synthesized magnetic composites with BAS have a high potential for use in the biomedical field, for example, as carriers for magnetically controlled drug delivery and materials for bone tissue engineering.
6 March 2018 in Proceedings of the National Academy of Sciences of Belarus, Chemical Series
Получены ассоциаты наночастиц (НЧ) магнетита, церия и их композита – Fe3O4/CeO2 с новыми амидами, содержащими фрагменты ингибиторов протеинкиназ и гистондеацетилаз. Неорганические частицы формировали в присутствии амидов, объединяя в одном процессе получение наноносителя и его функционализацию. Гидродинамический диаметр ассоциатов в 40-кратно разведенном золе увеличивается в ряду (СеО2)С2 < (Fe3O4)C2 < (Fe3O4/CeO2)C2. В водном растворе 0,05 н HCl, 155 мМ NaCl, имитирующем желудочный сок, время полупревращения агломератов магнетита и ассоциата (Fe3O4)С2 составляет 415 и 140 мин соответственно.